These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

715 related articles for article (PubMed ID: 16181002)

  • 1. Comparison of the aerosol velocity and spray duration of Respimat Soft Mist inhaler and pressurized metered dose inhalers.
    Hochrainer D; Hölz H; Kreher C; Scaffidi L; Spallek M; Wachtel H
    J Aerosol Med; 2005; 18(3):273-82. PubMed ID: 16181002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Higher lung deposition with Respimat Soft Mist inhaler than HFA-MDI in COPD patients with poor technique.
    Brand P; Hederer B; Austen G; Dewberry H; Meyer T
    Int J Chron Obstruct Pulmon Dis; 2008; 3(4):763-70. PubMed ID: 19281091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review of the development of Respimat Soft Mist Inhaler.
    Dalby R; Spallek M; Voshaar T
    Int J Pharm; 2004 Sep; 283(1-2):1-9. PubMed ID: 15363496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A review of ipratropium bromide/fenoterol hydrobromide (Berodual) delivered via Respimat Soft Mist Inhaler in patients with asthma and chronic obstructive pulmonary disease.
    Kässner F; Hodder R; Bateman ED
    Drugs; 2004; 64(15):1671-82. PubMed ID: 15257628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced Environmental Impact of the Reusable Respimat
    Hänsel M; Bambach T; Wachtel H
    Adv Ther; 2019 Sep; 36(9):2487-2492. PubMed ID: 31317391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of ipratropium bromide plus fenoterol inhaled via Respimat Soft Mist Inhaler vs. a conventional metered dose inhaler plus spacer in children with asthma.
    von Berg A; Jeena PM; Soemantri PA; Vertruyen A; Schmidt P; Gerken F; Razzouk H
    Pediatr Pulmonol; 2004 Mar; 37(3):264-72. PubMed ID: 14966821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oronasal and Tracheostomy Delivery of Soft Mist and Pressurized Metered-Dose Inhalers With Valved Holding Chamber.
    Berlinski A; Cooper B
    Respir Care; 2016 Jul; 61(7):913-9. PubMed ID: 27006348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of eco-friendly inhalers: focus on combination ipratropium bromide and albuterol in chronic obstructive pulmonary disease.
    Panos RJ
    Int J Chron Obstruct Pulmon Dis; 2013; 8():221-30. PubMed ID: 23658481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plume Characteristics of Two HFA-Driven Inhaled Corticosteroid/Long-Acting Beta2-Agonist Combination Pressurized Metered-Dose Inhalers.
    Johal B; Murphy S; Tuohy J; Marshall J
    Adv Ther; 2015 Jun; 32(6):567-79. PubMed ID: 26100350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fenoterol delivery by Respimat soft mist inhaler versus CFC metered dose inhaler: cumulative dose-response study in asthma patients.
    Vincken W; Dewberry H; Moonen D
    J Asthma; 2003 Sep; 40(6):721-30. PubMed ID: 14580004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deposition of corticosteroid aerosol in the human lung by Respimat Soft Mist inhaler compared to deposition by metered dose inhaler or by Turbuhaler dry powder inhaler.
    Pitcairn G; Reader S; Pavia D; Newman S
    J Aerosol Med; 2005; 18(3):264-72. PubMed ID: 16181001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preliminary data from phase II studies with Respimat, a propellant-free soft mist inhaler.
    Pavia D; Moonen D
    J Aerosol Med; 1999; 12 Suppl 1():S33-9. PubMed ID: 10623340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Respimat Soft Mist inhaler versus hydrofluoroalkane metered dose inhaler: patient preference and satisfaction.
    Schürmann W; Schmidtmann S; Moroni P; Massey D; Qidan M
    Treat Respir Med; 2005; 4(1):53-61. PubMed ID: 15725050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In Vitro Evaluation of Aerosol Performance and Delivery Efficiency During Mechanical Ventilation Between Soft Mist Inhaler and Pressurized Metered-Dose Inhaler.
    Ke WR; Wang WJ; Lin TH; Wu CL; Huang SH; Wu HD; Chen CC
    Respir Care; 2020 Jul; 65(7):1001-1010. PubMed ID: 32071134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental Study of Spiriva Respimat Soft Mist Inhaler Spray Characterization: Size Distributions and Velocity.
    Alatrash A; Mehri R; Ogrodnik N; Matida E; Fiorenza F
    J Aerosol Med Pulm Drug Deliv; 2019 Oct; 32(5):293-302. PubMed ID: 31259646
    [No Abstract]   [Full Text] [Related]  

  • 16. In vitro tests for aerosol deposition. III: effect of inhaler insertion angle on aerosol deposition.
    Delvadia RR; Longest PW; Hindle M; Byron PR
    J Aerosol Med Pulm Drug Deliv; 2013 Jun; 26(3):145-56. PubMed ID: 23025452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved delivery of ipratropium bromide/fenoterol from Respimat Soft Mist Inhaler in patients with COPD.
    Kilfeather SA; Ponitz HH; Beck E; Schmidt P; Lee A; Bowen I; Hesse Ch
    Respir Med; 2004 May; 98(5):387-97. PubMed ID: 15139567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Respimat
    Iwanaga T; Tohda Y; Nakamura S; Suga Y
    Clin Drug Investig; 2019 Nov; 39(11):1021-1030. PubMed ID: 31377981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the effectiveness of inhaler devices in asthma and chronic obstructive airways disease: a systematic review of the literature.
    Brocklebank D; Ram F; Wright J; Barry P; Cates C; Davies L; Douglas G; Muers M; Smith D; White J
    Health Technol Assess; 2001; 5(26):1-149. PubMed ID: 11701099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aerosol Plumes of Inhalers Used in COPD.
    Wachtel H; Emerson-Stadler R; Langguth P; Hohlfeld JM; Ohar J
    Pulm Ther; 2024 Mar; 10(1):109-122. PubMed ID: 38194194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.